We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ultrafast, Low-Cost Point-of-Care PCR Testing System Provides Central Lab Precision in 15 Minutes

By LabMedica International staff writers
Posted on 16 May 2023
Print article
Image: DASH (Diagnostic Analyzer for Specific Hybridization) quantitative PCR system (Photo courtesy of Minute Molecular)
Image: DASH (Diagnostic Analyzer for Specific Hybridization) quantitative PCR system (Photo courtesy of Minute Molecular)

Despite the rapid progress in medical testing, there's still a pressing demand for improved diagnostic and screening tools for infectious bacterial and viral pathogens. Currently, nucleic acid amplification tests (NAAT), such as RT-PCR, are the “gold standard” for accuracy, with the highest analytic sensitivity. However, PCR testing requires specialized lab equipment, significant technical knowledge, and is costly, time-intensive, and often inaccessible in remote or under-resourced areas. Now, a compact, portable platform that can be operated by non-technical personnel takes testing out of the traditional laboratory environment by consolidating the entire PCR testing process (sample extraction and PCR), providing results in approximately 15 minutes.

The DASH (Diagnostic Analyzer for Specific Hybridization) quantitative PCR system from Minute Molecular Diagnostics (Evanston, IL, USA) is roughly the size of a cereal box, making it compact enough to fit on a countertop or desk. DASH delivers the same accuracy as other PCR tests in a compact portable platform that can be utilized by non-technical personnel at the point of care. It identifies infectious bacterial and viral pathogens in under 15 minutes, requiring less than a minute of hands-on time. During the initial 10 minutes, samples are extracted and purified with sequence-specific capture probes. Paramagnetic particles (PMP) are introduced to bind to the target probe complex. Subsequently, the targets are magnetically separated from the swab extraction buffer, cleaned, and moved to the PCR chamber. During the final five minutes of the assay, 40 PCR temperature cycles are executed, with fluorescence measured via a four-channel optical system.

DASH's defining features are its user-friendly nature, quickness, and PCR-level precision. The DASH interface guides users through each step, making it as simple to operate as a coffee machine. Although initially conceived to combat the COVID-19 pandemic, the technology is versatile, capable of detecting a range of viral and bacterial pathogens. Presently, Minute Molecular Diagnostics is working on developing similar tests for influenza, HIV, Hepatitis C, several sexually transmitted diseases, MRSA, and C. diff, compatible with various sample types, including nasal swabs, saliva, and blood. The DASH PCR testing system can also provide a quantitative report of HIV and Hepatitis C viral loads. Its compact size facilitates testing in hospital and non-hospital settings. DASH units can be linked together to deliver between 4 and 24 test results per hour, making it an excellent choice for point-of-care testing in clinics, businesses, or community environments.

Related Links:
Minute Molecular Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more